• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.25%

    Advaxis, Inc. (ADXS)

    -NasdaqCM
    7.65 Down 0.08(1.03%) 9:31AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.73
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:11.67
    Beta:1.29
    Next Earnings Date:N/A
    Day's Range:7.65 - 7.88
    52wk Range:2.46 - 13.74
    Volume:65,158
    Avg Vol (3m):921,874
    Market Cap:180.88M
    P/E (ttm):N/A
    EPS (ttm):-0.97
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADXS

    Comparison

    Symbol% ChgMkt Cap
    ADXSDown 1.03%180.88M
    BVTI 0.00%N/A
    DNDNDown 13.61%N/A
    VICL 0.00%93.94M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):182.77
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Oct-15) :-1.11
    Quarterly EPS Est (Jan-15) :-0.29
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback